Skip to Content

New Drug Approvals Archive - May 2003

May 2003

Iressa (gefitinib) Tablets

Date of Approval: May 5, 2003
Company: AstraZeneca
Treatment for: Non-Small Cell Lung Cancer

Iressa (gefitinib) is a tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have specific epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

Velcade (bortezomib) for Injection

Date of Approval: May 13, 2003
Company: Millennium Pharmaceuticals
Treatment for: Multiple Myeloma

Velcade is an antineoplastic agent indicated for the treatment of multiple myeloma and mantle cell lymphoma.

New Drug Approvals Archive

2019January, February, March

2018January, February, March, April, May, June, July, August, September, October, November, December

2017January, February, March, April, May, June, July, August, September, October, November, December

2016January, February, March, April, May, June, July, August, September, October, November, December

2015January, February, March, April, May, June, July, August, September, October, November, December

2014January, February, March, April, May, June, July, August, September, October, November, December

2013January, February, March, April, May, June, July, August, September, October, November, December

2012January, February, March, April, May, June, July, August, September, October, November, December

2011January, February, March, April, May, June, July, August, October, November, December

2010January, February, March, April, May, June, July, August, September, October, November, December

2009January, February, March, April, May, June, July, August, September, October, November, December

2008January, February, March, April, May, June, July, August, September, October, November, December

2007January, February, March, April, May, June, July, August, September, October, November, December

2006January, February, March, April, May, June, July, August, September, October, November, December

2005January, February, March, April, May, June, July, August, September, October, November, December

2004January, February, March, April, May, June, July, August, September, October, November, December

2003January, February, March, April, May, June, July, August, September, October, November, December

2002January, February, April, May, July, August, October, November, December

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Recently Approved

Sunosi Sunosi (solriamfetol) is a selective dopamine and norepinephrine reuptake...
Zulresso Zulresso (brexanolone) is a gamma-aminobutyric acid A (GABAA) receptor...
Rocklatan Rocklatan (netarsudil and latanoprost ophthalmic solution) is a fixed dose...
Trazimera Trazimera (trastuzumab-qyyp) is a HER2 / neu receptor antagonist biosimilar to...

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com Pill Reminder

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 Mar 2019), Cerner Multum™ (updated 1 Mar 2019), Wolters Kluwer™ (updated 28 Feb 2019) and others. Refer to our editorial policy for content sources and attributions.